tiprankstipranks
Kane Biotech Inc (TSE:KNE)
TSXV:KNE
Canadian Market

Kane Biotech (KNE) Stock Price & Analysis

0 Followers

KNE Stock Chart & Stats

Day’s RangeC$0 - C$0
52-Week RangeC$0.05 - C$0.17
Previous CloseC$0.14
Volume205.29K
Average Volume (3M)191.92K
Market Cap
C$17.80M
Enterprise ValueC$27.51M
Total Cash (Recent Filing)C$1.62M
Total Debt (Recent Filing)C$9.16M
Price to Earnings (P/E)-3.9
Beta0.38
May 23, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding131,844,567
10 Day Avg. Volume715,124
30 Day Avg. Volume191,923
Standard Deviation0.13
R-Squared0.04
Alpha0.00776
Financial Highlights & Ratios
Price to Book (P/B)-1.78
Price to Sales (P/S)6.67
Price to Cash Flow (P/CF)-6.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

42.81%0.00%0.00%57.19%
42.81% Insiders
0.00% Other Institutional Investors
57.19% Public Companies and
Individual Investors

KNE FAQ

What was Kane Biotech Inc’s price range in the past 12 months?
Kane Biotech Inc lowest stock price was C$0.05 and its highest was C$0.17 in the past 12 months.
    What is Kane Biotech Inc’s market cap?
    Currently, no data Available
    When is Kane Biotech Inc’s upcoming earnings report date?
    Kane Biotech Inc’s upcoming earnings report date is May 23, 2024 which is in 20 days.
      How were Kane Biotech Inc’s earnings last quarter?
      Currently, no data Available
      Is Kane Biotech Inc overvalued?
      According to Wall Street analysts Kane Biotech Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Kane Biotech Inc pay dividends?
        Kane Biotech Inc does not currently pay dividends.
        What is Kane Biotech Inc’s EPS estimate?
        Kane Biotech Inc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Kane Biotech Inc have?
        Kane Biotech Inc has 131,844,570 shares outstanding.
          What happened to Kane Biotech Inc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Kane Biotech Inc?
          Currently, no hedge funds are holding shares in TSE:KNE
          ---

          Company Description

          Kane Biotech Inc

          Kane Biotech Inc is a Canada based biotechnology company engaged in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms. The company's human health product is DispersinB and animal health products include bluestem oral care, STRIX NB, and Alosera. In addition, the company also provides technologies for industrial applications such as medical device coating and hard surface disinfectant.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Helix BioPharma
          Medmira
          Avivagen
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis